Ensign Peak Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $48.4M | Sell |
|
|||||
|
2023
Q3 | $175M | Buy |
|
|||||
|
2023
Q2 | $178M | Buy |
|
|||||
|
2023
Q1 | $163M | Buy |
|
|||||
|
2022
Q4 | $144M | Buy |
|
|||||
|
2022
Q3 | $116M | Sell |
|
|||||
|
2022
Q2 | $176M | Buy |
|
|||||
|
2022
Q1 | $159M | Buy |
|
|||||
|
2021
Q4 | $49.9M | Buy |
|
|||||
|
2021
Q3 | $10.2M | Buy |
|
|||||
|
2021
Q2 | $9.87M | Buy |
|
|||||
|
2021
Q1 | $8.19M | Sell |
|
|||||
|
2020
Q4 | $8.75M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $9.79M | Buy |
|
|||||
|
2020
Q1 | $562K | Sell |
|
|||||
|
2019
Q4 | $2.83M | Buy |
|